Stock 300583 SHANDONG SITO BIO-TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shandong Sito Bio-technology Co., Ltd.

Equities

300583

CNE100002F36

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 03/06/2024 BST 		5-day change 1st Jan Change
12.82 CNY -1.38% Intraday chart for Shandong Sito Bio-technology Co., Ltd. -3.25% -35.19%
05-08 Shandong Sito Bio-technology Gets European Suitability Certification for Rhinitis Nasal Spray MT
04-28 Shandong Sito Bio-technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Shandong Sito Bio-technology Co Ltd is a company that provides raw materials for pharmaceutical companies. The Company operates three product segments. The Steroid Raw Materials segment is engaged in the manufacturing of steroid raw materials using genetic engineering technology and microbial transformation technology, such as androstenedione, androstenedione, 9-hydroxyandrostenedione, hydroxyprogesterone and so on. The Company also operates Steroidal Finished Drug segment and Non-Steroidal Finished Drug segment through its subsidiary.

Number of employees: 1,200

Sales per Business

CNY in Million2022Weight2023Weight Delta
Steroid Drug Raw Materials
87.9 %
1,163 88.7 % 1,125 87.9 % -3.29%
Other
11.6 %
153 11.6 % 148 11.6 % -2.94%
Steroidal and Non-steroidal Raw Materials and Finished Drugs
7.8 %
87 6.6 % 100 7.8 % +15.57%
Inter-segment Elimination
-7.3 %
-91 -6.9 % -94 -7.3 % +3.47%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
84.6 %
1,184 90.3 % 1,082 84.6 % -8.60%
Overseas
15.4 %
143 10.9 % 197 15.4 % +38.39%

Managers

Managers TitleAgeSince
Qi Mi CHM
 Chairman 34 15/01/19
Fu Wen Li DFI
 Director of Finance/CFO 48 31/12/12
Lu Li BRD
 Director/Board Member 47 15/01/19
Qing Li Zeng IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Xu Sheng Kong BRD
 Director/Board Member 63 15/11/20
Lu Li BRD
 Director/Board Member 47 15/01/19
Ya Ping Ma BRD
 Director/Board Member 50 15/11/20
Peng Fei Tu BRD
 Director/Board Member 61 15/11/20
Qi Mi CHM
 Chairman 34 15/01/19
Chao Chao Liu BRD
 Director/Board Member 39 12/10/17
Li Kang BRD
 Director/Board Member 51 12-07
Wen Xia Zhang CHM
 Chairman 39 15/11/20
Qi Ming Zhang BRD
 Director/Board Member 63 15/11/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 189,702,126 71,501,868 ( 37.69 %) 0 37.69 %

Shareholders

NameEquities%Valuation
HuaAn Fund Management Co., Ltd.
1.950 %
3,257,700 1.950 % 7 M ¥
Penghua Fund Management Co., Ltd.
1.810 %
3,022,260 1.810 % 6 M ¥
China Asset Management Co., Ltd.
0.9806 %
1,637,739 0.9806 % 3 M ¥
Guotai Asset Management Co., Ltd.
0.5984 %
999,520 0.5984 % 2 M ¥
Golden Trust Sinopac Fund Management Co., Ltd.
0.5514 %
921,000 0.5514 % 2 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.4926 %
822,700 0.4926 % 2 M ¥
Zhong Ou Asset Management Co., Ltd
0.4370 %
729,900 0.4370 % 1 M ¥
Fuanda Fund Management Co., Ltd.
0.4260 %
711,420 0.4260 % 1 M ¥
Golden Eagle Asset Management Co., Ltd.
0.1312 %
219,200 0.1312 % 445 272 ¥
Taiping Fund Management Co., Ltd.
0.0935 %
156,200 0.0935 % 317 297 ¥

Company contact information

Shandong Sito Bio-technology Co., Ltd.

South Section, Dongwaihuan Road Dingtao District

274100, Heze

+

http://www.sitobiotech.com
address Shandong Sito Bio-technology Co., Ltd.(300583)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
12.82
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANDONG SITO BIO-TECHNOLOGY CO., LTD. Stock Shandong Sito Bio-technology Co., Ltd.
-35.19% 341M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+42.83% 748B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.11% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.70% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.06% 325B
ABBVIE INC. Stock AbbVie Inc.
+4.63% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 245B
NOVARTIS AG Stock Novartis AG
+9.26% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-4.21% 209B
PFIZER, INC. Stock Pfizer, Inc.
+2.43% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300583 Stock
  4. Company Shandong Sito Bio-technology Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW